1. Home
  2. HROW vs GOOS Comparison

HROW vs GOOS Comparison

Compare HROW & GOOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HROW
  • GOOS
  • Stock Information
  • Founded
  • HROW 1998
  • GOOS 1957
  • Country
  • HROW United States
  • GOOS Canada
  • Employees
  • HROW N/A
  • GOOS N/A
  • Industry
  • HROW Biotechnology: Pharmaceutical Preparations
  • GOOS
  • Sector
  • HROW Health Care
  • GOOS
  • Exchange
  • HROW Nasdaq
  • GOOS Nasdaq
  • Market Cap
  • HROW 1.1B
  • GOOS 1.1B
  • IPO Year
  • HROW N/A
  • GOOS 2017
  • Fundamental
  • Price
  • HROW $30.66
  • GOOS $11.22
  • Analyst Decision
  • HROW Strong Buy
  • GOOS Sell
  • Analyst Count
  • HROW 6
  • GOOS 5
  • Target Price
  • HROW $59.00
  • GOOS $10.50
  • AVG Volume (30 Days)
  • HROW 433.0K
  • GOOS 1.2M
  • Earning Date
  • HROW 08-06-2025
  • GOOS 07-31-2025
  • Dividend Yield
  • HROW N/A
  • GOOS N/A
  • EPS Growth
  • HROW N/A
  • GOOS 70.17
  • EPS
  • HROW N/A
  • GOOS 0.68
  • Revenue
  • HROW $212,858,000.00
  • GOOS $943,742,214.00
  • Revenue This Year
  • HROW $44.92
  • GOOS $4.27
  • Revenue Next Year
  • HROW $38.12
  • GOOS $5.83
  • P/E Ratio
  • HROW N/A
  • GOOS $16.19
  • Revenue Growth
  • HROW 53.49
  • GOOS 1.09
  • 52 Week Low
  • HROW $19.31
  • GOOS $6.73
  • 52 Week High
  • HROW $59.23
  • GOOS $13.50
  • Technical
  • Relative Strength Index (RSI)
  • HROW 57.58
  • GOOS 54.64
  • Support Level
  • HROW $30.01
  • GOOS $10.97
  • Resistance Level
  • HROW $31.63
  • GOOS $11.52
  • Average True Range (ATR)
  • HROW 1.59
  • GOOS 0.39
  • MACD
  • HROW 0.02
  • GOOS -0.16
  • Stochastic Oscillator
  • HROW 66.10
  • GOOS 20.66

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About GOOS Canada Goose Holdings Inc. Subordinate Voting Shares

Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale and Direct to Consumer (DTC), Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market, and travel retail locations. Geographically, it has a presence in Canada, the United States, North America, Greater China, Asia, and Europe, the Middle East, and Africa.

Share on Social Networks: